Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1214Urinary Bladder Neoplasms 386Carcinoma, Renal Cell 329Kidney Neoplasms 205Neoplasms 157Breast Neoplasms 146Lung Neoplasms 101Carcinoma, Transitional Cell 99Colorectal Neoplasms 77Testicular Neoplasms 74Ovarian Neoplasms 62Melanoma 60Pancreatic Neoplasms 57Colonic Neoplasms 50Carcinoma, Non-Small-Cell Lung 50Head and Neck Neoplasms 47Stomach Neoplasms 45Non-Muscle Invasive Bladder Neoplasms 45Disease 45Neoplasm Metastasis 41Liver Neoplasms 40Uterine Cervical Neoplasms 39Esophageal Neoplasms 37Wilms Tumor 36Prostatic Hyperplasia 36Adenocarcinoma 33Multiple Myeloma 32Urologic Neoplasms 30Sarcoma 30Recurrence 30

Interventions

enzalutamide 1darolutamide 1apalutamide 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Advanced Prostate Carcinoma × Genitourinary × Clear all
NCT05612880 2025-01-09

Physical Function During ARSI Treatment

UNC Lineberger Comprehensive Cancer Center

Completed
24 enrolled
Genitourinary

Advanced Prostate Carcinoma

NCT04984395 2021-07-30

IDT

Royal Marsden NHS Foundation Trust

Unknown
50 enrolled
Genitourinary

Advanced Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡